Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Meilekang Pharmaceutical is a Chinese pharmaceutical company based in Haikou, Hainan Province, specializing in the development and manufacture of chemical generic drugs. Founded in 2011, the company operates out of the Yunlong Industrial Park with modern, GMP-certified facilities for oral solid dosage forms. Its product portfolio is heavily weighted toward anti-infectives, including a variety of cephalosporin and macrolide antibiotics. Additionally, the company produces treatments for gastrointestinal disorders, such as proton pump inhibitors, and respiratory ailments. Meilekang focuses on providing high-quality, affordable generic medications to the domestic Chinese market. The firm maintains a strong regional presence in the Hainan pharmaceutical cluster, emphasizing manufacturing excellence and regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Meilekang Pharmaceutical.